Literature DB >> 32424202

Antioxidative effect of an oral adsorbent, AST-120, and long-term outcomes in chronic kidney disease patients with cardiovascular disease.

Shigeru Toyoda1, Ryota Hashimoto2, Taiyo Tezuka2, Masashi Sakuma2, Shichiro Abe2, Tetsuya Ishikawa3, Isao Taguchi3, Teruo Inoue2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2020        PMID： 32424202     DOI： 10.1038/s41440-020-0465-6

Source DB:  PubMed          Journal:  Hypertens Res        ISSN： 0916-9636            Impact factor:   3.872


× No keyword cloud information.
  10 in total

1.  Impact of the oral adsorbent AST-120 on oxidative stress and uremic toxins in high-risk chronic kidney disease patients.

Authors:  Shigeru Toyoda; Migaku Kikuchi; Takaaki Komatsu; Yuichi Hori; Shiro Nakahara; Sayuki Kobayashi; Yoshihiko Sakai; Teruo Inoue; Isao Taguchi
Journal:  Int J Cardiol       Date:  2014-10-05       Impact factor: 4.164

2.  Usefulness of the d-ROMs test for prediction of cardiovascular events.

Authors:  Nobuyuki Masaki; Atsushi Sato; Syumpei Horii; Toyokazu Kimura; Takumi Toya; Risako Yasuda; Takayuki Namba; Hirotaka Yada; Akio Kawamura; Takeshi Adachi
Journal:  Int J Cardiol       Date:  2016-07-30       Impact factor: 4.164

3.  Clinical efficacy of an automated high-sensitivity C-reactive protein assay.

Authors:  N Rifai; R P Tracy; P M Ridker
Journal:  Clin Chem       Date:  1999-12       Impact factor: 8.327

4.  Renal function, neurohormonal activation, and survival in patients with chronic heart failure.

Authors:  H L Hillege; A R Girbes; P J de Kam; F Boomsma; D de Zeeuw; A Charlesworth; J R Hampton; D J van Veldhuisen
Journal:  Circulation       Date:  2000-07-11       Impact factor: 29.690

5.  Effect of a carbonaceous oral adsorbent on the progression of CKD: a multicenter, randomized, controlled trial.

Authors:  Tadao Akizawa; Yasushi Asano; Satoshi Morita; Takafumi Wakita; Yoshihiro Onishi; Shunichi Fukuhara; Fumitake Gejyo; Seiichi Matsuo; Noriaki Yorioka; Kiyoshi Kurokawa
Journal:  Am J Kidney Dis       Date:  2009-07-17       Impact factor: 8.860

6.  Accumulation of indoxyl sulfate, an inhibitor of drug-binding, in uremic serum as demonstrated by internal-surface reversed-phase liquid chromatography.

Authors:  T Niwa; N Takeda; A Tatematsu; K Maeda
Journal:  Clin Chem       Date:  1988-11       Impact factor: 8.327

7.  Estimated glomerular filtration rate as a predictor of secondary outcomes in Japanese patients with coronary artery disease.

Authors:  Keita Matsuo; Teruo Inoue; Koichi Node
Journal:  J Cardiol       Date:  2009-01-23       Impact factor: 3.159

8.  Three-year change in oxidative stress markers is linked to target organ damage in black and white men: the SABPA study.

Authors:  Caitlynd Myburgh; Hugo W Huisman; Catharina M C Mels
Journal:  Hypertens Res       Date:  2019-09-30       Impact factor: 3.872

9.  Long-term effects of peroxisome proliferator-activated receptor ligand bezafibrate on N-terminal pro-B type natriuretic peptide in patients with advanced functional capacity impairment.

Authors:  Koichi Node; Teruo Inoue; Valentin Boyko; Ilan Goldberg; Enrique Z Fisman; Yehuda Adler; Ehud Schwammenthal; Zipora Matas; Solomon Behar; Alexander Tenenbaum
Journal:  Cardiovasc Diabetol       Date:  2009-01-28       Impact factor: 9.951

Review 10.  Chronic Kidney Disease and Disproportionally Increased Cardiovascular Damage: Does Oxidative Stress Explain the Burden?

Authors:  Anila Duni; Vassilios Liakopoulos; Karolos-Pavlos Rapsomanikis; Evangelia Dounousi
Journal:  Oxid Med Cell Longev       Date:  2017-11-23       Impact factor: 6.543
  10 in total
  2 in total

Review 1.  Chronic Kidney Disease and Gut Microbiota: What Is Their Connection in Early Life?

Authors:  Chien-Ning Hsu; You-Lin Tain
Journal:  Int J Mol Sci       Date:  2022-04-02       Impact factor: 5.923

Review 2.  Roles of Gut Microbial Metabolites in Diabetic Kidney Disease.

Authors:  Qing Fang; Na Liu; Binjie Zheng; Fei Guo; Xiangchang Zeng; Xinyi Huang; Dongsheng Ouyang
Journal:  Front Endocrinol (Lausanne)       Date:  2021-05-20       Impact factor: 5.555
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.